Surya Pharma

Rediff.com » News » Surya Pharma

News for Surya Pharma

Business

Pricing challenge in US biz, rich valuations may weigh on pharma stocks

The tailwind of low price erosion in the US generics market, seen by domestic pharmaceutical companies in calendar year 2023 (CY23), may be reversing slowly, caution analysts. Illustration: Uttam......

Market litmus may turn red for chemicals sector

The chemicals sector’s recovery could be delayed until FY25 if the current trends of weak demand and flat pricing continue. Photograph: Lisi Niesner/Reuters Following a subdued September......

IPO investors sitting on 50% gains

Investors who had subscribed to a slew of initial public offerings this year are a smiling lot.The aggregate market value of these shares has appreciated by almost 50 per cent i.e. from Rs 11,767......

Interesting pharma picks for your portfolio

Surya Narayan Patra of SSKI & Sharekhan discusses his picks from the pharma space.Patra states that Elder Pharma's results were in line with their expectations. According to him, the company has......

Why Dr Reddy's expects FY19 to be stronger and richer

The US drug regulator raised the issue of significant deviations from the current good manufacturing practice (cGMP) in three of DRRD's plants in a letter issued in November 2015 Investors......

Rediff News

Surya Pharma

News for Surya Pharma

Pricing challenge in US biz, rich valuations may weigh on pharma stocks

Market litmus may turn red for chemicals sector

IPO investors sitting on 50% gains

Interesting pharma picks for your portfolio

Why Dr Reddy's expects FY19 to be stronger and richer

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS